Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1976 1
1979 1
1986 2
1987 1
1988 2
1989 6
1990 4
1991 1
1992 1
1993 2
1994 4
1995 2
1996 1
1997 3
1998 3
1999 4
2000 5
2001 10
2002 21
2003 27
2004 15
2005 16
2006 16
2007 11
2008 13
2009 12
2010 6
2011 13
2012 12
2013 11
2014 13
2015 12
2016 19
2017 6
2018 17
2019 21
2020 16
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

323 results
Results by year
Filters applied: . Clear all
Page 1
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial.
Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, Smith EC, McDonald CM, Zaidman CM, Morgenroth LP, Osaki H, Satou Y, Yamashita T, Hoffman EP; CINRG DNHS Investigators. Clemens PR, et al. Among authors: satou y. JAMA Neurol. 2020 Aug 1;77(8):982-991. doi: 10.1001/jamaneurol.2020.1264. JAMA Neurol. 2020. PMID: 32453377 Free PMC article. Clinical Trial.
Blood and lymphatic systems are segregated by the FLCN tumor suppressor.
Tai-Nagara I, Hasumi Y, Kusumoto D, Hasumi H, Okabe K, Ando T, Matsuzaki F, Itoh F, Saya H, Liu C, Li W, Mukouyama YS, Marston Linehan W, Liu X, Hirashima M, Suzuki Y, Funasaki S, Satou Y, Furuya M, Baba M, Kubota Y. Tai-Nagara I, et al. Among authors: satou y. Nat Commun. 2020 Dec 9;11(1):6314. doi: 10.1038/s41467-020-20156-6. Nat Commun. 2020. PMID: 33298956 Free PMC article.
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.
Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, Eto M, Yao M, Kamba T, Suda T, Oike Y, Schmidt LS, Linehan WM. Baba M, et al. Among authors: satou y. Mol Cancer Res. 2019 Aug;17(8):1613-1626. doi: 10.1158/1541-7786.MCR-18-1235. Epub 2019 May 1. Mol Cancer Res. 2019. PMID: 31043488 Free PMC article.
Ascidian Zic Genes.
Satou Y, Imai KS. Satou Y, et al. Adv Exp Med Biol. 2018;1046:87-106. doi: 10.1007/978-981-10-7311-3_6. Adv Exp Med Biol. 2018. PMID: 29442319 Review.
T-cell dysregulation in COVID-19.
Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. Kalfaoglu B, et al. Among authors: satou y. Biochem Biophys Res Commun. 2021 Jan 29;538:204-210. doi: 10.1016/j.bbrc.2020.10.079. Epub 2020 Nov 7. Biochem Biophys Res Commun. 2021. PMID: 33220925 Free PMC article.
Urochordate genomes.
Satoh N, Kawashima T, Shoguchi E, Satou Y. Satoh N, et al. Among authors: satou y. Genome Dyn. 2006;2:198-212. doi: 10.1159/000095105. Genome Dyn. 2006. PMID: 18753780 Review.
323 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page